Last updated on June 2018

A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)


Brief description of study

The main purpose of this study is to compare maintenance treatment with avelumab plus best supportive care (BSC) with BSC alone, to determine if avelumab has an effect on survival in patients with locally advanced or metastatic urothelial cancer that did not worsen during or following completion of first-line chemotherapy.

Clinical Study Identifier: NCT02603432

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Hospital Universitario Infanta Sofia
San Sebastian de los Reyes, Spain
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario Infanta Sofia
San Sebastián de los Reyes, Spain
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario HM Sanchinarro - CIOCC
Madrid, Spain
6.19miles
  Connect »

Pfizer CT.gov Call Center

Hospital Ruber Internacional
Madrid, Spain
6.95miles
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario Ramon y Cajal_Oncology department
Madrid, Spain
6.95miles
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario Ramon y Cajal
Madrid, Spain
6.95miles
  Connect »

Pfizer CT.gov Call Center

Hospital Ruber International
Madrid, Spain
6.95miles
  Connect »

Pfizer CT.gov Call Center

Hospital Universitario La Paz
Madrid, Spain
8.28miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.